Cao Pharmaceuticals
Heads the Investor Relations with over 30 years of finance, accounting, information technology, management, and business ownership experience. He is currently coordinating investor relations and securing funding to complete the CZ48 FDA Phase I trial and begin the FDA Phase II trials.
This person is not in any offices
Cao Pharmaceuticals
Cao Pharmaceuticals is an early clinical-stage oncology drug development company.